These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35998389)

  • 41. Degradation of ricin A chain by endosomal and lysosomal enzymes--the protective role of ricin B chain.
    Bilge A; Howell-Clark J; Ramakrishnan S; Press OW
    Ther Immunol; 1994 Aug; 1(4):197-204. PubMed ID: 7584495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vinyldeoxyadenosine in a sarcin-ricin RNA loop and its binding to ricin toxin a-chain.
    Roday S; Saen-oon S; Schramm VL
    Biochemistry; 2007 May; 46(21):6169-82. PubMed ID: 17477546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ricin. Mechanisms of cytotoxicity.
    Lord MJ; Jolliffe NA; Marsden CJ; Pateman CS; Smith DC; Spooner RA; Watson PD; Roberts LM
    Toxicol Rev; 2003; 22(1):53-64. PubMed ID: 14579547
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Bhattacharya S; Dahmane T; Goger MJ; Rudolph MJ; Tumer NE
    Biomol NMR Assign; 2024 Jun; 18(1):85-91. PubMed ID: 38642265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ricin A-chain inhibitors resembling the oxacarbenium ion transition state.
    Tanaka KS; Chen XY; Ichikawa Y; Tyler PC; Furneaux RH; Schramm VL
    Biochemistry; 2001 Jun; 40(23):6845-51. PubMed ID: 11389598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional divergence between the two P1-P2 stalk dimers on the ribosome in their interaction with ricin A chain.
    Grela P; Li XP; Tchórzewski M; Tumer NE
    Biochem J; 2014 May; 460(1):59-67. PubMed ID: 24576056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N-glycosylation does not affect the catalytic activity of ricin a chain but stimulates cytotoxicity by promoting its transport out of the endoplasmic reticulum.
    Yan Q; Li XP; Tumer NE
    Traffic; 2012 Nov; 13(11):1508-21. PubMed ID: 22882900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pentameric organization of the ribosomal stalk accelerates recruitment of ricin a chain to the ribosome for depurination.
    Li XP; Grela P; Krokowski D; Tchórzewski M; Tumer NE
    J Biol Chem; 2010 Dec; 285(53):41463-71. PubMed ID: 20974854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
    Kornfeld SB; Leonard JE; Mullen MD; Taetle R
    Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure-based design of ricin inhibitors.
    Jasheway K; Pruet J; Anslyn EV; Robertus JD
    Toxins (Basel); 2011 Oct; 3(10):1233-48. PubMed ID: 22069693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of binding ligand in toxic hybrid proteins: a comparison of EGF-ricin, EGF-ricin A-chain, and ricin.
    Herschman HR
    Biochem Biophys Res Commun; 1984 Oct; 124(2):551-7. PubMed ID: 6333873
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidermal growth factor-toxin A chain conjugates: EGF-ricin A is a potent toxin while EGF-diphtheria fragment A is nontoxic.
    Cawley DB; Herschman HR; Gilliland DG; Collier RJ
    Cell; 1980 Nov; 22(2 Pt 2):563-70. PubMed ID: 6256086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detecting ricin: sensitive luminescent assay for ricin A-chain ribosome depurination kinetics.
    Sturm MB; Schramm VL
    Anal Chem; 2009 Apr; 81(8):2847-53. PubMed ID: 19364139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in Ribosome Binding and Sarcin/Ricin Loop Depurination by Shiga and Ricin Holotoxins.
    Li XP; Tumer NE
    Toxins (Basel); 2017 Apr; 9(4):. PubMed ID: 28398250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The isolation and characterization of temperature-dependent ricin A chain molecules in Saccharomyces cerevisiae.
    Allen SC; Moore KA; Marsden CJ; Fülöp V; Moffat KG; Lord JM; Ladds G; Roberts LM
    FEBS J; 2007 Nov; 274(21):5586-99. PubMed ID: 17916187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of RTA ricin subunit inhibitors: a computational study using PM7 quantum chemical method and steered molecular dynamics.
    Chaves EJF; Gomes da Cruz LE; Padilha IQM; Silveira CH; Araujo DAM; Rocha GB
    J Biomol Struct Dyn; 2022 Aug; 40(12):5427-5445. PubMed ID: 33526002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural Analysis of Toxin-Neutralizing, Single-Domain Antibodies that Bridge Ricin's A-B Subunit Interface.
    Rudolph MJ; Poon AY; Kavaliauskiene S; Myrann AG; Reynolds-Peterson C; Davis SA; Sandvig K; Vance DJ; Mantis NJ
    J Mol Biol; 2021 Jul; 433(15):167086. PubMed ID: 34089718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL2 fused to lectin-deficient ricin is toxic to human leukemia cells expressing the IL2 receptor.
    Frankel AE; Fu T; Burbage C; Chandler J; Willingham MC; Tagge EP
    Leukemia; 1997 Jan; 11(1):22-30. PubMed ID: 9001414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ricin trafficking in cells.
    Spooner RA; Lord JM
    Toxins (Basel); 2015 Jan; 7(1):49-65. PubMed ID: 25584427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural Analysis of Single Domain Antibodies Bound to a Second Neutralizing Hot Spot on Ricin Toxin's Enzymatic Subunit.
    Rudolph MJ; Vance DJ; Cassidy MS; Rong Y; Mantis NJ
    J Biol Chem; 2017 Jan; 292(3):872-883. PubMed ID: 27903650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.